Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.
D000818:Animals; D003131:Combined Modality Therapy; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D017710:Lymphocyte Transfusion; D051379:Mice; D055502:Secondary Prevention; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods*